Back to All Events
Understanding a Rebalancing Therapy Option for Hemophilia
Sponsored by Pfizer
Speaker: Brad Schoenfeld, Director of Advocacy and Community Engagement, Pfizer
Hosted by: Dr. David Clark
Understanding a Rebalancing Therapy Option for Hemophilia
Description -
Join us for an educational session exploring a rebalancing treatment option for hemophilia.
You’ll hear:
• The science behind rebalancing therapy
• Clinical trial data
• Safety information
• Information on administration
• Shared decision-making tips for patients and caregivers
In this session, we’ll dive into a rebalancing treatment option. From how it works to clinical trial learnings, you’ll gain the latest information to help you or your loved ones understand this treatment option with confidence.
Previous
Previous
October 6
A Blueprint for Confidence: Making Informed Choices in Hemophilia B With IDELVION
Next
Next
October 8